Shionogi (SH00) Stock Overview
Engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 2/6 |
| Past Performance | 4/6 |
| Financial Health | 5/6 |
| Dividends | 5/6 |
SH00 Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Shionogi & Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | JP¥8.45 |
| 52 Week High | JP¥9.70 |
| 52 Week Low | JP¥7.10 |
| Beta | 0.033 |
| 1 Month Change | -1.74% |
| 3 Month Change | -12.89% |
| 1 Year Change | 19.01% |
| 3 Year Change | 23.06% |
| 5 Year Change | n/a |
| Change since IPO | -2.35% |
Recent News & Updates
Recent updates
Shareholder Returns
| SH00 | DE Pharmaceuticals | DE Market | |
|---|---|---|---|
| 7D | -0.6% | 6.1% | 3.2% |
| 1Y | 19.0% | 27.3% | 2.5% |
Return vs Industry: SH00 underperformed the German Pharmaceuticals industry which returned 27.3% over the past year.
Return vs Market: SH00 exceeded the German Market which returned 2.5% over the past year.
Price Volatility
| SH00 volatility | |
|---|---|
| SH00 Average Weekly Movement | 2.0% |
| Pharmaceuticals Industry Average Movement | 6.4% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in DE Market | 13.3% |
| 10% least volatile stocks in DE Market | 2.7% |
Stable Share Price: SH00 has not had significant price volatility in the past 3 months compared to the German market.
Volatility Over Time: SH00's weekly volatility (2%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1878 | 4,955 | Isao Teshirogi | www.shionogi.com |
Shionogi & Co., Ltd. engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan and internationally. It is also involved in consumer healthcare business; manufacturing, sale, analytical testing, and pharmaceutical engineering of medicinal drugs and investigational drugs; contracted monitoring of epidemiological components in sewage; promotion of implementation in social infrastructure; and business related to providing data and information; develops and sells foothold; and research and development of mucosal vaccines. In addition, the company provides contract support services for experimental research; contract testing of agricultural production materials; solutions for education and healthcare, system development, human resource development, and training business; marketing support services; and IT services for medical and healthcare-related issues.
Shionogi & Co., Ltd. Fundamentals Summary
| SH00 fundamental statistics | |
|---|---|
| Market cap | €13.63b |
| Earnings (TTM) | €1.11b |
| Revenue (TTM) | €2.70b |
Is SH00 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| SH00 income statement (TTM) | |
|---|---|
| Revenue | JP¥499.68b |
| Cost of Revenue | JP¥82.45b |
| Gross Profit | JP¥417.23b |
| Other Expenses | JP¥212.07b |
| Earnings | JP¥205.16b |
Last Reported Earnings
Mar 31, 2026
Next Earnings Date
Jul 30, 2026
| Earnings per share (EPS) | 241.09 |
| Gross Margin | 83.50% |
| Net Profit Margin | 41.06% |
| Debt/Equity Ratio | 39.1% |
How did SH00 perform over the long term?
See historical performance and comparisonDividends
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/05/24 14:33 |
| End of Day Share Price | 2026/05/22 00:00 |
| Earnings | 2026/03/31 |
| Annual Earnings | 2026/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Shionogi & Co., Ltd. is covered by 22 analysts. 11 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Atsushi Seki | Barclays |
| Miki Sogi | Bernstein |
| Koichi Mamegano | BofA Global Research |